|
(11) | EP 0 263 161 A1 |
(12) |
|
|
|
|
|||||||||||||||||||
(54) | ANTIBODY PREPARATION DIRECTED AGAINST NEOANTIGENS IN HUMAN C3 (COMPLEMENT FACTOR 3) AND THE USE AND MANUFACTURE THEREOF |